Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Pharmiva

Less than 1K followers
All
Press releases
3rd party
ShowingAll content types

Regulatory press release2023-11-10 09:01

Bolagsverket meddelar tillstånd till fusionen mellan Peptonic och Pharmiva

Pharmiva
Regulatory press release2023-10-31 09:33

Nasdaq First North Growth Market godkänner Pharmivas ansökan om avnotering

Pharmiva
Regulatory press release2023-10-12 08:40

Pharmiva offentliggör preliminär tidplan avseende fusionen med Peptonic

Pharmiva

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2023-10-12 08:30

Pharmiva ansöker om avnotering från Nasdaq First North Growth Market villkorat av slutförande av fusionen med Peptonic

Pharmiva
Regulatory press release2023-09-11 11:54

Pharmiva senarelägger sin delårsrapport för tredje kvartalet

Pharmiva
Regulatory press release2023-09-06 16:10

Pharmiva avslutar klinisk studie av Vernivia

Pharmiva
Press release2023-08-23 12:22

Carlsquare Equity Research ser positiva signaler för Pharmivas sammanslagning med Peptonic och tror den kan ”tända elden”

Pharmiva
Press release2023-08-23 12:02

Carlsquare: Equity Research, Pharmiva: Merger with Peptonic could spark the fire

Pharmiva
Press release2023-08-21 13:00

Samgåendet mellan Peptonic och Pharmiva skapar ett ledande globalt femtech-bolag

Pharmiva
Regulatory press release2023-08-21 10:49

Kommuniké från extra bolagsstämma i Pharmiva AB

Pharmiva
Regulatory press release2023-08-16 07:15

Pharmiva publicerar Q2-rapport för 2023

Pharmiva
Regulatory press release2023-08-02 12:00

Kallelse till extra bolagsstämma i Pharmiva AB

Pharmiva
Regulatory press release2023-07-07 08:40

Uttalande från styrelsen i Pharmiva med anledning av fusionen med Peptonic

Pharmiva
Regulatory press release2023-07-07 08:35

Peptonic och Pharmiva offentliggör fusionsplan

Pharmiva
Regulatory press release2023-07-07 08:30

Pharmiva redovisar preliminära siffror för perioden 1 januari – 31 maj 2023

Pharmiva
Regulatory press release2023-06-15 13:00

Pharmiva och Peptonic tecknar avsiktsförklaring för att gå samman och bilda nya Peptonic

Pharmiva
Regulatory press release2023-05-24 16:13

Kommuniké från årsstämma i Pharmiva AB

Pharmiva
Press release2023-05-24 10:09

Vd Anna Linton presenterar Pharmiva på Sedermeradagen i Stockholm 30 maj

Pharmiva
Regulatory press release2023-05-24 07:33

Pharmiva publicerar Q1-rapport för 2023

Pharmiva
Regulatory press release2023-04-20 16:06

Kallelse till årsstämma i Pharmiva AB

Pharmiva